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Abstract 14 
An advanced potentiometric electronic tongue and Sequential Injection Analysis (SIA) 15 
measurement system was applied for the quantitative analysis of mixtures containing 16 
three active pharmaceutical ingredients (APIs): acetaminophen, ascorbic acid and 17 
acetylsalicylic acid, in the presence of various amounts of caffeine as interferent. The 18 
flow-through sensor array was composed of miniaturized classical ion-selective 19 
electrodes based on plasticized PVC membranes containing only ion exchangers. 20 
Partial Least Squares (PLS) analysis of the steady-state sensor array responses, 21 
measured in API mixtures prepared by the SIA system permitted a correct 22 
quantitative analysis of acetylsalicylic acid and ascorbic acid. Further optimization 23 
using multiway PLS fed by dynamic responses without additional feature extraction 24 
did not improve significantly the resolution of acetaminophen. Lastly, the 25 
chemometric treatment, involving the extraction of dynamic components of the 26 
transient response employing the Wavelet transform, the removal of less-significant 27 
coefficients by means of Causal Index pruning and training of an Artificial Neural 28 
Network (ANN) with the selected coefficients, allowed the simultaneous 29 
determination of all the three studied APIs, while counterbalancing any interference 30 
due to caffeine. 31 
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1. Introduction 36 
 37 
Multidrug pharmaceutical preparations containing paracetamol and non-steroidal 38 
anti-inflammatory drugs (NSAID) such as acetylsalicylic acid or ibuprofen are 39 
commonly used for the flue treatment and flu-like illnesses. Frequently, they are 40 
combined with antihistamines e.g. diphenhydramine and pheniramine maleate and 41 
other active pharmaceutical ingredients (APIs) as caffeine, codeine, derivatives of 42 
pyrazolones, barbiturates. Paracetamol and NSAIDs are applied for treatment of mild 43 
to moderate pain and fever, while the antihistamines prevent many of the symptoms 44 
of an allergic reaction like nasal congestion. Addition of codeine or caffeine improves 45 
the pharmacological efficiency of paracematol and NSAIDs. Moreover, the multidrug 46 
formulations are less harmful to the main metabolic organs, because smaller amount 47 
of each component are introduced in comparison with monocomponent drug [1,2]. 48 
Since analgesic drugs as acetylsalicylic acid, ibuprofen or paracetamol are generally 49 
available over the counter (OTC) they are daily used by millions of people for 50 
household relief of pain and thus accidental and deliberate overdose are common. 51 
Paracetamol is a tolerable drug in standard dose, while NSAIDs often cause gastro-52 
toxicity which is depended on dose and product. High risk of gastrointestinal bleeding 53 
is especially associated with taking even low-dose of aspirin, whereas ibuprofen 54 
seems to carry lower risk of gastro-toxicity. Regarding the extended use of such 55 
formulations, the development of analytical methods for the quality assessment of 56 
these products is needed [3,4]. 57 
The analysis of pharmaceuticals involves pre-clinical and early phase clinical studies 58 
of a candidate for a new drug as well as routine analysis during production. 59 
Preclinical studies include the characterisation of a drug, identification of the effective 60 
dose and range and the tissues in which side effects may occur. During clinical trials, 61 
high-performance liquid chromatography (HPLC), UV-Vis spectrophotometry and 62 
potentiometric titration are useful to characterize drugs in 0 (preclinical) and I phase 63 
of clinical trials [5]. Moreover, several methods of API analysis in pure form, mixtures 64 
and commercial products have been reported. HPLC is the most common technique 65 
used for targeted NSAID analysis, especially coupled with MS detection employing 66 
different ionization systems [6,7]. As an example, HPLC with optical detection was 67 
applied for the determination of active pharmaceutical ingredients: paracetamol, 68 
acetylsalicylic acid, caffeine in pharmaceutical preparations [1,2,8,9]. Conventional 69 
and derivative spectrophotometry, often combined with chemometric procedures, was 70 
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also proposed for the multi- component analysis of drugs [10-14]. Voltammetric 71 
measurements at modified or unmodified electrodes enabled the resolution of various 72 
pharmaceutical compounds [15-18]. 73 
On the other hand, portable and compact electrochemical sensors, providing fast 74 
measurements with high selectivity and sensitivity, could be competitive to classical 75 
instrumental techniques dedicated for the analysis of pharmaceuticals. Among them, 76 
potentiometric sensors – ion-selective electrodes (ISEs) – are the most promising for 77 
such purpose [19,20]. ISEs based on polymer membranes doped with the ion-pair 78 
complex of tetraoctylammonium cation were developed for the analysis of ibuprofen 79 
[21,22]. Similar approach was proposed for the design of ion-selective electrodes 80 
sensitive towards: naproxen [23], ketoprofen [24] and caffeine [25]. It is worth to note, 81 
that the use of potentiometric sensors provided measurements in flow injection mode 82 
(see a review on the application of Flow Injection Analysis (FIA) and Sequential 83 
Injection Analysis (SIA) for pharmaceutical analysis in [26]). 84 
Recently, electronic tongue (e-tongue) systems composed of sensor arrays and 85 
pattern recognition tools were tested in pharmaceutical applications [27-29]. Since 86 
the majority of commonly used active pharmaceutical ingredients have a bitter taste, 87 
various methods for taste masking were developed and the e-tongue devices were 88 
exploited for the evaluation of the efficiency of such methods. An array of classical or 89 
miniaturized ISEs was proposed for the assessment of taste masking effect of 90 
selected pharmaceuticals modified with co-spray excipients (microencapsulation 91 
method) [29,30]. Potentiometric multisensor systems were employed for the 92 
quantification of the bitter taste of diverse active pharmaceutical ingredients [31,32]. 93 
Finally, the performances of commercial e-tongues dedicated to the analysis of 94 
pharmaceutical formulations were also compared [27,33,34]. 95 
In this work, an automated method for the quantitative analysis of selected active 96 
pharmaceutical ingredients (acetaminophen, ascorbic acid, and acetylsalicylic acid) 97 
involving an array of miniaturized potentiometric electrodes based on well-known 98 
lipophilic salts (ion-exchangers) was reported. Calibration and measurement with the 99 
electrode array was implemented with the aid of sequential injection analysis (SIA) 100 
system. Among different measurement conditions and data treatment, incorporation 101 
of dynamic components of the transient response is reported as the means to 102 
improve modeling capability and resolution. 103 
 104 
 105 
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2. Experimental 106 
 107 
2.1. Chemicals and membrane materials 108 
 109 
The active pharmaceutical ingredients (APIs): acetaminophen pKa=9.50 110 
(paracetamol, PARA), ascorbic acid pKa=4.17 (ASC), acetylsalicylic acid pKa=3.50 111 
(ASA) were purchased from Sigma-Aldrich, whereas hydrochloric acid, lithium 112 
acetate, tris(hydroxymethyl)aminomethane (TRIS) and caffeine pKa=0.70 (KOF) of 113 
analytical grade were purchased from Fluka. The solutions of APIs (0.04 mol/L 114 
acetaminophen, 0.014 mol/L ascorbic acid, 0.016 mol/L acetylsalicylic acid), caffeine 115 
(2.6 mmol/L), lithium acetate (1 mmol/L), TRIS buffer solution (1 mmol/L) were 116 
prepared with deionised water. The pH of solutions was adjusted by the addition of 117 
hydrochloric acid or sodium hydroxide solution. High-molecular-weight poly(vinyl 118 
chloride) (PVC), plasticizers: o-nitrophenyl octyl ether (o-NPOE), bis(2-ethylhexyl) 119 
sebacate (DOS), lipophilic salts: potassium tetrakis [3,5-bis(trifluoromethyl)phenyl] 120 
borate (KTFPB), tridodecylmethylammonium chloride (TDMAC), 121 
tributylhexadecylphosphonium bromide (TBHDPB) and ionic liquid 1-decyl-3-122 
methylimidazolium chloride (IL) were obtained from Fluka. Freshly distilled 123 
tetrahydrofuran (Fluka) was used as a solvent for the membrane components. 124 
 125 
2.2. Sensor array 126 
 127 
The flow-through sensor array consisted of 8 miniaturized electrodes based on PVC 128 
membranes (plasticized using DOS or o-NPOE), containing an appropriate lipophilic 129 
salt, exhibiting generic anion (TDMAC, TBHDPB, IL) or cation (KTFBB) response. 130 
Two electrode specimens were prepared for each membrane composition. The 131 
method of membranes preparation and electrodes conditioning were the same as for 132 
the standard ISEs. The membranes contained: 1-3.5 wt% lipophilic salt, 64-66 wt% 133 
plasticizer, 32-33 wt% high-molecular-weight PVC (see Table 1). The membrane 134 
components (200 mg in total) were dissolved in 2 mL of THF. A detailed architecture 135 
of the miniaturized ion-selective electrodes compatible with a single flow-through 136 
module was presented in [35], whereas the design of the modular flow-cell system is 137 
a subject of a polish patent application [36]. NaCl solution (0.01 mol/L) was used as 138 
an internal filling. The constructed sensors were preconditioned overnight in a dilute 139 
solution of internal electrolyte for at least 24 hours. 140 
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2.3. Instrumentation and EMF measurements 141 
 142 
All measurements were carried out in flow-through mode with cells of the following 143 
type: Ag, AgCl; KCl 3 mol/L│CH3COOLi 1 mol/L│sample solution║membrane║ 144 
internal filling solution; AgCl, Ag. 145 
Potentiometric multiplexer (EMF 16 Interface, Lawson Labs Inc., Malvern, USA) was 146 
used for the characterization of the sensors. The calibration curves of the electrodes 147 
were examined by measuring the EMFs while increasing the concentration of the 148 
APIs in steps of 0.5 log c in the range 10-5.5 – 10-1.5 mol/L (10-5.5 – 10-2 mol/L for 149 
acetylsalicylic acid). Repeatable sensor performances were recorded during at least 150 
4 weeks. 151 
For the quantitative analysis of APIs mixtures, the flow-through sensor array was 152 
connected to the Sequential Injection Analysis (SIA) system providing the automated 153 
operation and generation of API samples mixtures, thanks to the precise dosing and 154 
mixing of volumes of stock solutions. The SIA system was formed by two 155 
differentiated parts: the fluidic system and the measurement system [37,38], which 156 
were wholly controlled by a PC using a virtual instrument developed in LabView, 157 
where the other active elements were commanded through RS-232 communication 158 
lines. 159 
The fluidic system consisted of an automatic microburette (Crison 2030 microburette, 160 
Crison, Spain) equipped with a 5-mL syringe (Hamilton, Switzerland), a holding coil 161 
(5m×1mm i.d. PTFE tubing, Bioblock, France), a 8-way Hamilton MVP valve 162 
(Hamilton, Switzerland) and a 7mL Perspex mixing cell (home built) with a magnetic 163 
stirrer. The burette was connected to the multiport valve through the holding coil 164 
placed in between, and fed through a carrier solution reservoir. In this way, 165 
connection between the common port to the other ones (i.e. sample, standard stock 166 
solutions, mixing chamber or sensor array port) was achieved by an electrical 167 
rotation of the valve; all the elements being connected together using low pressure 168 
liquid chromatography connectors. 169 
The measurement system comprised the sensor array, a reference electrode 170 
(miniaturised silver/silver chloride electrode with a double junction) and an 8-channel 171 
signal conditioning circuit connected to the data acquisition analog inputs (National 172 
Instruments NI6221 Multifunction DAQ, TX, USA). 173 
 174 
 175 
 6
2.4. Data analysis 176 
 177 
Data analysis was performed in MatLab (The MathWorks, Inc., Natick, USA), Solo 178 
(Eigenvector Research, Inc., Wenatchee, USA) and Origin (Microcal Software, Inc, 179 
Northampton, USA) software. Chemical images of samples were processed using 180 
Partial Least Squares (PLS) analysis in the case of models involving steady-state 181 
signals, and 3-way PLS in the case of models based on dynamic responses of the 182 
sensors. Analogously, ANN models were also built employing the dynamic 183 
responses, but in this case requiring a preprocessing step aimed to the reduction of 184 
signals complexity and dimensionality [39]. This was achieved by means of Discrete 185 
Wavelet Transform (DWT) as feature extraction tool and Causal Index (CI) pruning of 186 
the inputs to remove less-significant extracted coefficients that barely contribute to 187 
the final model. 188 
 189 
 190 
3. Results and discussion 191 
 192 
The studied active pharmaceutical ingredients remain in neutral or anionic form in 193 
solution, according to their pKa values and pH conditions. Therefore, anion-sensitive 194 
electrodes based on various ion-exchangers were applied for the quantitative 195 
analysis of selected APIs. The electrodes constructed by incorporating 196 
tetraalkylammonium and phosphonium salts in the PVC/o-NPOE membranes 197 
exhibited almost theoretical values of the response slopes for acetylsalicylic acid (in 198 
the range 10-4 – 10-2 mol/L), whereas significantly worse response sensitivities (<20 199 
mV/decade) were measured for the weak acids: acetaminophen and ascorbic acid, 200 
even in alkaline conditions. Comparable, poor sensitivity was observed in the case of 201 
potentiometric sensors based on ionic liquid (1-decyl-3-methylimidazolium chloride) 202 
towards all APIs, recorded in different pH conditions. 203 
Additional cation-sensitive electrodes based on KTFPB in PVC/DOS membranes 204 
were introduced to the sensor array, since the studied mixtures of APIs contained 205 
also caffeine – a component commonly added to the pharmaceutical formulations 206 
with anti-inflammatory drugs. However, due to the very low value of pKa, the neutral 207 
form of caffeine was predominant in solution under the studied pH range [25] and 208 
thus the electrodes showed rather small and non-linear response to this component. 209 
 210 
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3.1. Quantitative analysis of APIs – PLS and 3-way PLS 211 
 212 
The measurements of the sensor array signals were conducted in 80 sample 213 
mixtures containing 3 APIs in different concentration ranges (1-20 mmol/L for 214 
acetaminophen, 0.3-7 mmol/L for ascorbic acid and 1.4-8 mmol/L for acetylsalicylic 215 
acid), prepared automatically by the Sequential Injection Analysis system (Figure 1) 216 
[36,37]. The given concentration ranges were matched to the level of such APIs in 217 
commercial drugs after their dissolution in water. Caffeine, added to each mixture 218 
(0.13-1.3 mmol/L), was considered as an interferent (see Figure 1). The experiments 219 
were performed in solutions at various pH in order to alter the structure of APIs and 220 
sense individual components in particular pH conditions. Therefore, four carriers of 221 
different pH: HCl solution (pH=1.8), lithium acetate solution (pH=5.0) and TRIS buffer 222 
solution (pH=8.0 and pH=10.5) were used. In these solutions anionic species of 223 
acetaminophen were present only at pH=10.5 (existed in small amounts at pH=8.0), 224 
whereas acetylsalicylic acid and ascorbic acid remained in appreciable amount in 225 
neutral form only at pH=1.8. 226 
Data matrices involving the steady-state signals of the sensors after step introduction 227 
of the samples were formed. Target matrices contained direct information on 3 APIs 228 
concentrations (three-column calibration) or on 1 API concentration (single-column 229 
calibration). Various variants of train data were considered (but in each case, 4:1 data 230 
division was used to form the train and the test set, respectively): 231 
 4 PLS models based on data from single measurements in the given pH, 232 
 6 PLS models based on the combination of signals recorded in solutions of 2 233 
values of pH, 234 
 4 PLS models based on the combination of signals recorded in solutions of 3 235 
values of pH, 236 
 1 PLS model based on the combination of all signals recorded in all 4 values of 237 
pH. 238 
The PLS models were built with a number of Latent Variables (1 to 8 for PLS and 20 239 
for 3-way PLS) enabling the minimization of the RMSE value. Their performance was 240 
characterized after performing the linear fitting of the obtained data (PLS predicted 241 
concentrations of API) versus the expected data (real concentrations of API). The 242 
values of the slope (“a”), intercept (“b”) and determination coefficient (“R2”), were 243 
calculated for the train and test samples, assuming that in the perfect case they 244 
should reach values of 1, 0 and 1, respectively. It was found, that the data 245 
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dimensionality i.e. the combination of data from the experiments performed in various 246 
pH conditions influenced the classification results. The best results were obtained for 247 
the fusion of signals recorded in solutions of pH: 1.8, 8.0, 10.5 (see Table 2). 248 
However, the concentration of only 2 APIs i.e. acetylsalicylic acid and ascorbic acid 249 
was properly predicted. Even though acetaminophen should be in the anionic form in 250 
the solution of highest pH value, the responses of the electrodes to this API did not 251 
provide satisfactory result. Therefore, single-column calibration was attempted i.e. 252 
separate PLS-1 models were created for each API, based on the fusion of signals 253 
recorded in the same 3 values of pH. The same train and test data matrices were 254 
used; however the target matrix was limited to one column – concentration of single 255 
API. Unfortunately, the prediction of API concentration remained unsatisfactory, 256 
especially for acetaminophen (Table 2).  257 
In the next step, dynamic responses of the sensor array were applied in the train data 258 
for multiway processing to enhance the amount of information gained by PLS model. 259 
Whole responses (1800 data points per sensor) and the initial 30s of sensors 260 
responses (first 300 data points per sensor) recorded in various combinations of pH 261 
were used in multiway models. Better results were obtained in the case of 3-way PLS 262 
analysis, but only for the train subset. Still, the results obtained for the test subsets 263 
were not satisfactory, which was caused by poor prediction abilities of the 3-way PLS 264 
models (see Table 3). However, quite better results were noticed when whole 265 
dynamic response was considered (1800 points). 266 
 267 
3.2. Quantitative analysis of APIs – DWT-ANN 268 
 269 
As an alternative approach, the usage of ANNs was also considered. Compared with 270 
PLS, ANNs are more flexible modelling methodologies, since both linear and non-271 
linear functions (or its combination) can be used in the processing units, thus being 272 
especially suited when sensor responses show non-linear behaviors [39,40]. 273 
Moreover, allowing for more complex relationships between a high-dimensional 274 
descriptor space and the given retention data, which might lead to better predictive 275 
power of the resulting ANN model compared with other linear methods, although if 276 
linearity exists, a proper behavior will be obtained also with the latter. 277 
In this way, same approaches as previously described were also followed, i.e. the 278 
usage of the steady state signal and building of models based on single- and multi-279 
pH values, with the same data division for the train and test subsets. However, none 280 
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of those approaches provided enough satisfactory results. The next step was then 281 
the usage of the dynamic profile, as previously done with 3-way PLS. Nevertheless, 282 
this was not as straightforward as in the previous case, as in here, before building the 283 
ANN model, a preprocessing step devised for reducing the input dimensionality was 284 
required. 285 
For the dynamic treatment, a two-step feature extraction process was thus followed 286 
to achieve the reduction of signals complexity and dimensionality. Firstly, the 287 
response profile of each sensor was compressed employing DWT, and afterwards 288 
ANNs were used as feature selection tool for variable selection [39]. In this way, the 289 
dynamic potentiometric response (from 2.1s to 10.0s, comprising a total of 80 values; 290 
see Figure 2) was compressed employing Daubechies wavelet mother function and a 291 
second decomposition level down to 25 coefficients, without any loss of relevant 292 
information. The obtained coefficients were then fed to an ANN model, which upon its 293 
training, was used for the removal of the less-significant coefficients by Causal Index 294 
(CI) pruning of the inputs [39,40]. This process was then iteratively repeated until 295 
selection of an optimal subset of coefficients that allows doing the prediction task as 296 
well as possible, with as few variables as possible. Lastly, the architecture of the ANN 297 
model was optimized, as usual, by systematically fine-tuning its topology (i.e. training 298 
algorithm, number of hidden layers, number of neurons, transfer functions, etc.) to 299 
achieve the correct quantification of the desired compounds. 300 
Subsequently, after pruning and optimization of the ANN model, comparison graphs 301 
of predicted vs. expected scores, both for the train and test subsets, were built 302 
(Figure 3) and the linear fitted regression parameters were calculated to easily check 303 
the performance of the model (Table 4). As can be seen, acetylsalicylic acid (ASA) 304 
can be perfectly modelled in all the cases with low difficulty, while counterbalancing 305 
the changing concentrations of caffeine. On the other side, acetaminophen (PARA) 306 
and ascorbic acid (ASC) modelling was also plausible, although obtained correlation 307 
seem to be worst. Nevertheless, in all cases the obtained regression parameters 308 
were close to the ideal ones; i.e. values of intercept close to 0, and slope and R2 309 
close to 1. 310 
 311 
 312 
 313 
 314 
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4. Conclusions 315 
 316 
HPLC systems with UV detection are commonly applied for the routine analysis of 317 
non-steroidal anti-inflammatory drugs (e.g. acetylsalicylic acid) in pharmaceutical 318 
pain relievers. However, sophisticated instrumentation and skilled personnel are 319 
essential to provide the proper chromatographic results. Therefore, a simpler 320 
analytical approach based on sensor arrays systems would be beneficial due to the 321 
automation and shortening of the analysis. 322 
In this work, a flow-through sensor array of miniaturized potentiometric electrodes 323 
containing only an ion-exchanger in polymeric membranes coupled with Sequential 324 
Injection Analysis system was proposed for the quantitative analysis of selected 325 
active pharmaceutical ingredients. Simple chemometric data processing involving 326 
Partial Least Squares (PLS) analysis of the steady-state responses of the sensors as 327 
well as multiway PLS fed by dynamic sensors responses enabled the determination 328 
of acetylsalicylic acid and ascorbic acid in mixtures, while correcting any interference 329 
derived from the presence of acetaminophen and caffeine. However, the extraction of 330 
dynamic components of the transient response employing the Wavelet transform, the 331 
removal of the less significant inputs by means of Causal Index pruning and training 332 
of an Artificial Neural Network with the selected coefficients allowed the simultaneous 333 
determination of the 3 APIs counterbalancing any interference caused by caffeine. 334 
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Table 1. Components used for the preparation of potentiometric electrodes. 410 
 411 
Electrode 
type Lipophilic salt Plasticizer Polymer 
Internal filling/ 
Conditioning solution 
1 3.5 wt% TDMAC 64.0 wt% o-NPOE 32.5 wt% PVC 
0.01/0.001 mol/L 
NaCl 
 
2 2.0 wt% TBHDPB 65.5 wt% o-NPOE 32.5 wt% PVC 
3 2.0 wt% IL 65.5 wt% o-NPOE 32.5 wt% PVC 
4 1.0 wt% KTFPB 66.0 wt% DOS  33.0 wt% PVC 
412 
 14
Table 2. Parameters of linear fitting of real and PLS-predicted concentration of APIs. 413 
 414 
 
Three-column calibration Single-column calibration 
acetaminophen ascorbic acid  acetylsalicylic acid acetaminophen ascorbic acid  
acetylsalicylic 
acid 
TRAIN 
a 0.72±0.06 0.84±0.05 0.98±0.02 0.22±0.05 0.68±0.06 0.94±0.03 
b 0.00±0.00 0.00±0.00 0.00±0.00 0.01±0.00 0.00±0.00 0.00±0.00 
R2 0.72 0.84 0.98 0.22 0.68 0.94 
TEST 
a 0.52±0.28 0.60±0.20 0.96±0.03 0.11±0.08 0.58±0.19 0.94±0.04 
b 0.01±0.00 0.00±0.00 0.00±0.00 0.01±0.00 0.00±0.00 0.00±0.00 
R2 0.19 0.41 0.98 0.12 0.40 0.98 
415 
 15
Table 3. Parameters of linear fitting of real and 3-way PLS-predicted concentration of 416 
APIs. 417 
 418 
 
Calibration based on 1800 data points Calibration based on 300 data points 
acetaminophen ascorbic acid  acetylsalicylic acid acetaminophen ascorbic acid  
acetylsalicylic 
acid 
TRAIN 
a 0.86±0.04 0.75±0.08 0.98±0.08 0.69±0.06 0.65±0.06 0.98±0.01 
b 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 
R2 0.96 0.92 0.99 0.91 0.89 0.99 
TEST 
a 0.31±0.18 0.80±0,19 0.97±0.05 0.60±0.12 0.41±0.10 0.97±0.03 
b 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 
R2 0.00 0.45 0.96 0.62 0.49 0.98 
  419 
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Table 4. Parameters of linear fitting of real and DWT-CI-ANN-predicted concentration of 420 
APIs. 421 
 422 
 acetaminophen ascorbic acid  acetylsalicylic acid 
TRAIN 
a 0.96±0.02 0.96±0.01 0.98±0.01 
b 0.37±0.17 0.13±0.04 0.084±0.057 
R2 0.99 1.00 1.00 
TEST 
a 0.98±0.27 1.00±0.35 1.03±0.09 
b -0.42±3.00 0.13±1.23 -0.11±0.39 
R2 0.82 0.73 0.98 
423 
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Figure captions: 424 
Figure 1. Random distribution of concentrations of the four species for the (●) train 425 
and (★) test samples prepared automatically by the SIA system. 426 
Acetaminophen (PARA), ascorbic acid (ASC) and acetylsalicylic acid 427 
(ASA) are plotted in x,y,z coordinates respectively, whereas caffeine (KOF) 428 
is plotted as a color-scale in the scatter plot. 429 
Figure 2. Exemplary dynamic responses of the electrode based on TDMAC (PVC/o-430 
NPOE membrane) recorded in arbitrary mixture of APIs (1.4 mmol/L 431 
acetaminophen, 0.91 mmol/L ascorbic acid, 6.6 mmol/L acetylsalicylic acid 432 
and 0.68 mmol/L caffeine) in 4 carriers at various pH values  433 
Figure 3. Model performances characterized after linear fitting of the real 434 
concentrations of APIs to the predicted data by the DWT-CI-ANN model. 435 
Train set (●, solid line), test set (○, dotted line) and theoretical diagonal line 436 
(dashed line). 437 
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